Minisymposium on Endogenous Carcinogens: The Catechol Estrogen Pathway. An Introduction
Author:
- 1 August 1994
- journal article
- Published by Taylor & Francis in Polycyclic Aromatic Compounds
- Vol. 6 (1) , 223-228
Abstract
A major carcinogenic risk for many human cancers may be associated with endogenous procarcinogens that are precursors to carcinogens. If natural protective mechanisms become insufficient, these procarcinogens can be activated, giving rise to formation of endogenous carcinogens. Catechol estrogens (CE), which are metabolites of the estrogens estrone and 17β-estradiol are hypothesized to be such ubiquitous procarcinogens. Their oxidation to CE semiquinones and/or quinones can generate the DNA damage that leads to the tumor initiation process. In addition, redox cycling of CE semiquinones and quinones can generate free radicals that lead to enhancement of DNA damage. The minisymposium discussing this area of research was moderated by Pentti Siiteri and introduced by Ercole Cavalieri. It included presentations by Joachin Liehr, Judith Weisz, Cyrus Creveling and Herman Adlercreutz.Keywords
This publication has 6 references indexed in Scilit:
- Synthesis and characterization of estrogen 2,3- and 3,4-quinones. Comparison of DNA adducts formed by the quinones versus horseradish peroxidase-activated catechol estrogensChemical Research in Toxicology, 1992
- Variations in catechol O-methyltransferase activity in rodent tissues: possible role in estrogen carcinogenicityCarcinogenesis, 1989
- Semiquinone anion radicals of catechol(amine)s, catechol estrogens, and their metal ion complexes.Environmental Health Perspectives, 1985
- Searches for ultimate chemical carcinogens and their reactions with cellular macromoleculesCancer, 1981
- Cholinergic inputs to the amygdala and the control of gonadotrophin releaseEuropean Journal of Endocrinology, 1980
- Adenocarcinoma of the VaginaNew England Journal of Medicine, 1971